Canadian health officials to hold monkeypox update after WHO declares emergency – Global News
Canadian health officials will provide a monkeypox update on Wednesday after the World Health Organization (WHO) declared the outbreak a global health emergency over the weekend.
The briefing comes as Canada’s confirmed monkeypox case count hit 681 on July 23. Globalnews.ca will be live-streaming the update, which is scheduled to begin at 1 p.m. EDT.
Majority of the country’s cases have been found in Quebec and Ontario, which logged 331 and 288, respectively, as of July 23. British Columbia has 48 confirmed cases, Alberta with 12, and Saskatchewan with two.
Since July 1, Canada has seen monkeypox cases double, including the first in Saskatchewan and the first in a female in Ontario, Public Health Agency of Canada (PHAC) officials said on July 23. Infections are expected to continue to rise as the outbreak evolves, they added.
More than 18,000 monkeypox cases have been reported in 78 countries since its unusual emergence in the West this spring, WHO officials said on Wednesday. More than 70 per cent of cases have been found in Europe, and 25 per cent have been traced to the Americas. It declared the outbreak a global health emergency on July 23.
Hundreds of cases of monkeypox reported in Canada
So far, five deaths have been linked to the outbreak and 10 per cent of cases have needed hospital admission. Roughly 98 per cent of cases have been among men who have sex with other men, WHO officials said, urging caution that the virus can spread to anyone as it’s not limited to one group.
Monkeypox, which causes flu-like symptoms and skin lesions, is transmitted to humans from animals caused by an orthopoxvirus, which is related to smallpox, according to PHAC.
Individuals can be infected through direct contact with an infected person or by shared contaminated objects, including bed linens or towels. The disease mainly occurs in west and central Africa and only occasionally spreads elsewhere.
Last month, Canada’s National Advisory Committee on Immunization (NACI) recommended Canadians who are at high risk of contracting monkeypox — not just those who have been infected — get a vaccine.
Anyone with a high risk of exposure to a probable or confirmed case of monkeypox, or who has visited a setting where transmission of the virus is happening, should receive one dose of the Imvamune vaccine, NACI said.
NACI also said vaccines may be offered to those who are immunocompromised, pregnant or lactating, or children and youth, if they are at a higher risk of exposure.
Imvamune, normally used to treat smallpox, has been approved by Health Canada to treat monkeypox. To date, Ottawa has shipped more than 70,000 doses of vaccines to provinces and territories.
Right now, mass vaccination is not recommended, WHO officials said on Wednesday. Canadian health officials have said the overall risk to the general public remains low.
While vaccination is expected to provide protection, a successful monkeypox outbreak response relies on many public health measures including targeted public health education and equipping people with the information they need to make informed choices, PHAC said on July 23.
Toronto sees increased demand for monkeypox vaccine
To reduce the risk of becoming infected or spreading monkeypox, PHAC advises Canadians to stay home and limit contact with others if they have symptoms, which include fever, headache, fatigue and muscle aches.
Canadians can also stay protected by avoiding close physical contact, including sexual contact, with someone who is infected with or may have been exposed to the monkeypox virus, maintaining good hand hygiene and respiratory etiquette and cleaning and disinfecting high-touch surfaces and objects in your home, especially after having visitors.
“PHAC continues to work closely with international, provincial and territorial health partners to gather information on this evolving outbreak and to assess the possible risk of exposure of the monkeypox virus in Canada,” PHAC officials said in its July 23 statement.
“Canada will continue to work with the WHO and international partners to strengthen the global response to the current monkeypox outbreak.”
© 2022 Global News, a division of Corus Entertainment Inc.
Health unit suspends 1,900 students for incomplete immunization records – Windsor Star
More than 1,900 elementary school students in Windsor and Essex County have been suspended for out-of-date immunization records, the Windsor-Essex County Health Unit said Monday.
Parents must provide the health unit with an up-to-date immunization record for the suspension to be lifted and the student to return to school. Immunization clinics are available at both health unit locations in Windsor and Leamington on Monday and throughout this week, while immunization records are accepted in-person between 8:30 a.m. and 4:30 p.m. Monday to Friday at both locations.
Students who were suspended but attend and receive vaccinations at the health unit clinics, or who update their records with the health unit, will receive a notice and can return to school the same day.
Proof of immunization can also be submitted online at immune.wechu.org. Primary care providers can also send immunization records to the health unit at 519-258-7288.
The Immunization of School Pupils Act requires local health units to maintain and review vaccination records for all students and to enforce school suspensions if records are incomplete. These routine immunizations are often administered by primary care providers, but records must still be updated and on file with the health unit.
The review of student immunization records began in December 2022, when more than 12,000 students received notice their records were not up to date.
Earlier this month the health unit warned 3,200 students faced suspension for incomplete records; ultimately 1,908 were suspended on Monday, according to health officials.
Visit wechu.org/getimmunized for information and clinic times.
COVID-19 hair loss: Experts weigh in on PRP therapy – CTV News
The list of ways a COVID-19 infection disrupts the body’s natural functions is long and diverse, and, as Viktorya Skrypnyk’s clients have come to learn, includes hair loss.
Skrypnyk is a registered nurse who owns and operates VBeauty Spa, a medical aesthetic clinic in Toronto. The last two years have sent a parade of people through the doors of her clinic struggling with hair loss they say began after a COVID-19 infection.
“Lately, I do see that there’s people that are coming in that have no history of hair loss in the family, no history of alopecia that are developing these symptoms of alopecia within last few years,” she told CTVNews.ca on Friday. “Most of them are saying that they generally noticed an increase in the year loss specifically after acquiring COVID.”
Multiple published studies have shown COVID infections can trigger a type of hair shedding called telogen effluvium (TE). With TE, thinning typically occurs around the top of the head.
When clients suffering from TE come to Skrypnyk, it’s usually for a treatment she offers known as platelet-rich plasma (PRP) therapy. Before the pandemic, Skrypnyk estimates 70 per cent of her PRP therapy clients were men. Now?
“Lately I’ve noticed, after COVID especially, it’s been more popular among women,” she said.
WHAT IS PRP THERAPY?
Platelet-rich plasma therapy is a form of regenerative medicine that uses a patient’s own blood cells – specifically platelets – to accelerate healing in a specific area of the body.
Plasma is the liquid portion of blood; the medium that carries red and white blood cells and platelets through the body. It’s made mostly of water and proteins. Platelets are blood cells that aid in blood clotting and contain a naturally-occurring substance called growth factor, which stimulates cell growth and wound healing.
In PRP therapy, a patient’s blood is collected and spun in a centrifuge to concentrate the platelet component of the blood. The patient’s own platelet-rich plasma is then injected into an area of the body that needs help with growth or healing, like an injured muscle or, in some cases, a scalp losing hair.
“We usually withdraw the platelets and re-inject them back into the hairline, specifically where there’s a lot of hair loss,” Skrypnyk said.
PRP meets the definition of a drug under Canada’s Food and Drugs Act, but isn’t covered by provincial health insurance plans. At VBeauty Spa, a treatment typically costs $600, though other clinics may charge more or less.
According to an entry by doctors Neera Nathan and Maryanne Makredes Senna in the Harvard Health Blog, most of the research on PRP for hair loss has looked at its use to treat androgenetic alopecia, also known as hormone-related baldness. Androgenetic alopecia affects both men and women, resulting in balding at the crown and front of the head in men, and balding that begins with a widening of the part in women.
“There is not enough evidence to make conclusions about the effectiveness of PRP for other types of hair loss, like telogen effluvium, alopecia areata or forms of scarring hair loss,” Nathan and Senna wrote.
YOUR MILEAGE MAY VARY
A person can elect to receive PRP therapy for any type of hair loss, but Dr. Jeff Donovan cautions it should only be considered as a second- or third-line treatment for most patients and most types of hair loss.
“PRP is very popular, but the overwhelming message that I would have is that there is no hair loss condition for which PRP is the first-line option,” Donovan told CTVNews.ca in a phone interview on Friday.
Donovan is a dermatologist and member of the Canadian Dermatology Association who specializes in hair loss. Like Skrypnyk, he sometimes treats patients using PRP therapy. However, he rarely uses it to treat the type of hair loss most commonly linked to COVID-19 infections – telogen effluvium – and he never prescribes it as a first-line treatment.
For one thing, he explained, TE normally resolves on its own after four to eight months, as long as the condition that triggered it has resolved. It often doesn’t respond to the typical hair loss treatments.
“Telogen effluvium is a hair loss condition that happens due to a trigger,” Donovan told CTVNews.ca on Friday. “The treatment for telogen effluvium involves treating the trigger, not a bandaid with some other treatment plan.”
If a patient’s TE was triggered by low iron, treatment would involve restoring their iron levels, he said. Likewise, TE triggered by a thyroid condition, or a condition like anorexia nervosa, should resolve after the underlying condition has been treated.
In rare cases, Donovan will recommend PRP therapy for a patient suffering from TE for which an underlying cause can’t be pinpointed. More often, he’ll recommend it for patients suffering from other types of hair loss, but even then, only after exhausting other treatment options.
“When we speak about treatment for hair loss, we must speak about what is the first line treatment, what is the second line treatment and what is the third line treatment,” he said. “These are treatment ladders according to evidence-based medicine.”
For a client with alopecia areata, a type of hair loss that results in circular bald patches, Donovan said the first-line treatments are topical steroid injections and topical minoxidil, which is the active ingredient in Rogaine. For genetic hair loss or androgenetic hair loss, Donovan would first recommend oral and topical minoxidil as well as topical and oral anti-androgens.
Among clients who do end up using PRP therapy, Donovan said between 20 and 40 per cent will see mild benefits, such as a slower rate of hair loss or some modest growth. In order for PRP therapy to provide long-term benefits, however, Donovan said clients typically need to return for treatments three times per year, indefinitely.
Like Skrypnyk, Donovan has noticed more people seeking out PRP therapy for TE in the past year or two. However, he cautions against shelling out for the treatment before speaking to a doctor.
“Due to the popular nature of PRP and the marketing that goes into PRP, there has been an increase in the number of patients demanding that therapy,” he said. “However, that is not necessarily reflective of the benefit of the treatment. Nor is it reflective of how these conditions should be managed based on current scientific evidence.”
Instead, Dovovan said anyone who has hair loss concerns should start by seeking a diagnosis from their usual health-care provider, who can screen for underlying triggers and suggest treatments.
“In my practice, I really prefer when patients come after having tried several therapies,” he said, “because then I get a sense of how well the hair is responding to certain types of treatments.”
'Worrisome' deadly fungus spreading through US at alarming rate – Sky News
A drug-resistant and potentially deadly fungus is spreading rapidly through US health facilities, according to a government study.
Researchers from the Centres for Disease Control and Prevention (CDC) reported the fungus, a type of yeast called Candida auris or C. auris, can cause severe illness in people with weakened immune systems.
The number of people diagnosed, as well as the number who were found through screening to be carrying C. auris, has been rising at an alarming rate since the fungus was first reported in the US in 2016.
The fungus was identified in 2009 in Asia, but scientists have said C. auris first appeared around the world about a decade earlier.
Dr Meghan Lyman, chief medical officer of the CDC’s mycotic diseases branch, said the increases, “especially in the most recent years, are really concerning to us”.
“We’ve seen increases not just in areas of ongoing transmission, but also in new areas,” she said.
Dr Lyman also said she was concerned about the increasing number of fungus samples resistant to the common treatments for it.
Dr Waleed Javaid, an epidemiologist and director of infection prevention and control at Mount Sinai Downtown in New York, said the fungus was “worrisome”.
“But we don’t want people who watched ‘The Last Of Us’ to think we’re all going to die,” Dr Javaid said.
“This is an infection that occurs in extremely ill individuals who are usually sick with a lot of other issues.”
Is The Last Of Us’ real ‘zombie’ fungus an actual threat?
The fungus, which can be found on the skin and throughout the body, is not a threat to healthy people.
But about one-third of people who become sick with C. auris die.
The fungus has been detected in more than half of all US states. The number of infections in the US increased by 95% between 2020 and 2021.
Species of fungus discovered in Scotland
Fungal infections ‘increased significantly’ during COVID pandemic
The new research comes as Mississippi is facing a growing outbreak of the fungus.
Since November, 12 people in the state have been infected with four “potentially associated deaths”, according to the state’s health department.
‘No limits partnership’: Xi and Putin’s economic priorities – Al Jazeera English
Worst city in Canada for bed bugs revealed | CTV News – CTV News Toronto
War Made Easy: Norman Solomon on How Mainstream Media Helped Pave Way for U.S. Invasion of Iraq – Democracy Now!
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Search for life on Mars accelerates as new bodies of water found below planet’s surface
News11 hours ago
Gestational diabetes is on the rise and a Canadian study may have found out why – Global News
Tech23 hours ago
YouTuber Spends $22,000 to Buy Every Wii U and 3DS Game Ahead of Nintendo eShop Shutdown
Health10 hours ago
COVID-19 hair loss: Experts weigh in on PRP therapy – CTV News
Politics13 hours ago
This ain't no party, but populism is destroying our federal politics – The Hill Times
News17 hours ago
B.C. parent launches class-action lawsuit against makers of Fortnite video game
News17 hours ago
Canada denies role in detention, torture of former Guantanamo Bay detainee
Tech21 hours ago
How AI could upend the world even more than electricity or the internet
Investment11 hours ago
Exclusive-Credit Suisse tells staff plans for investment banking to be informed later -memo – Yahoo Canada Finance